Alexander Dimitrief - Mar 2, 2025 Form 4 Insider Report for Sotera Health Co (SHC)

Signature
Matthew J. Klaben, Attorney-in-Fact
Stock symbol
SHC
Transactions as of
Mar 2, 2025
Transactions value $
-$102,391
Form type
4
Date filed
3/4/2025, 08:34 PM
Previous filing
Aug 19, 2024
Next filing
May 16, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SHC Common Stock, $0.01 par value per share ("Common Stock") Tax liability -$102K -8.21K -2.86% $12.47 279K Mar 2, 2025 Direct F1
transaction SHC Common Stock Award $0 +56.1K +20.11% $0.00 335K Mar 3, 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SHC Performance RSUs Award $0 +28K $0.00 28K Mar 3, 2025 Common Stock 28K Direct F4
holding SHC Stock Options 102K Mar 2, 2025 Common Stock 102K $14.59 Direct F5, F6
holding SHC Stock Options 602K Mar 2, 2025 Common Stock 602K $6.37 Direct F5, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 17,135 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 4, 2024. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to recieve one share of Common Stock, subject to vesting conditions.
F2 These securities consist of RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026.
F3 These securities consist of 90,323 RSUs and 244,402 shares of Common Stock that have vested.
F4 These securities consist of a maximum number of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The additional RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance.
F5 No transaction is being reported on this line. Reported on a previously filed Form 4.
F6 These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions.
F7 These options were granted on November 7, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in two equal installments on each of October 31, 2023 and October 31, 2024, subject to the Reporting Person's continued service through each such date.

Remarks:

The Power of Attorney for Mr. Dimitrief is filed as an exhibit to the Form 3 filed on November 8, 2022, which is hereby incorporated by reference.